Treatment of oral lichen planus using deucravacitinib
JAAD Case Rep
.
2023 Dec 27:44:94-97.
doi: 10.1016/j.jdcr.2023.12.006.
eCollection 2024 Feb.
Authors
Mindy Vu
1
2
,
Rama Abdin
3
,
Naiem T Issa
1
2
4
Affiliations
1
Forefront Dermatology, Vienna, Virginia.
2
Issa Research and Consulting, LLC, Springfield, Virginia.
3
Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida.
4
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
PMID:
38351970
PMCID:
PMC10861938
DOI:
10.1016/j.jdcr.2023.12.006
No abstract available
Keywords:
deucravacitinib; oral lichen planus; treatment; tyrosine kinase 2 inhibitor.
Publication types
Case Reports